Show simple item record

dc.contributor.authorFluck, Richard
dc.date.accessioned2016-11-01T14:53:16Z
dc.date.available2016-11-01T14:53:16Z
dc.date.issued2016-11
dc.identifier.citationAm J Kidney Dis. 2016 Nov;68(5S1):S51-S58. doi: 10.1053/j.ajkd.2016.05.020.language
dc.identifier.urihttp://hdl.handle.net/20.500.12904/749
dc.description.abstractAlthough intensive hemodialysis (HD) can address important clinical problems, increasing treatment also introduces risks. In this review, we assess risks pertaining to 6 domains: vascular access complications, infection, mortality, loss of residual kidney function, solute balance, and patient and care partner burden. In the Frequent Hemodialysis Network (FHN) trials, short da ily and nocturnal schedules increased the incidence of access complications, although the incidence of access loss was not statistically higher. Observational studies indicate that infection-related hospitalization is an ongoing challenge with short daily HD. Excess risk may be catalyzed by poor infection control practices in the home setting in which intensive HD is typically delivered, but with fixed probability of bacterial contamination per cannulation, greater treatment frequency necessarily increases the risk for infectious complications. Buttonhole cannulation may increase the risk for metastatic infections. However, intensive HD in the home setting is associated with lower risk for infection than peritoneal dialysis. Data regarding mortality are equivocal. With extended follow-up of individuals in the FHN trials, short daily HD was associated with lower risk relative to the usual schedule, whereas nocturnal HD was associated with higher risk. In many, but not all, observational studies, short daily HD has been associated with lower risk than both in-center HD and peritoneal dialysis; however, observational studies are subject to unmeasured confounding. Intensive HD can accelerate the loss of residual kidney function in new dialysis patients with substantial urine output and can deplete solutes (eg, phosphorus) to the extent that supplementation is necessary. Finally, intensive HD may increase burden on patients and caregivers, possibly leading to technique failure. Some of these problems might be addressed with careful monitoring, so that relevant interventions (eg, antibiotics, retraining, and respite care) can be delivered. Ultimately, intensive HD is not a panacea for end-stage renal disease. Potential benefits and risks of treatment should be jointly considered.language
dc.language.isoenlanguage
dc.subjectButtonhole Cannulationlanguage
dc.subjectChronic Kidney Diseaselanguage
dc.subjectHaemodialysislanguage
dc.subjectEnd Stage Renal Diseaselanguage
dc.subjectResidual Renal Functionlanguage
dc.subjectTechnique Failurelanguage
dc.subjectSurvivallanguage
dc.titleIntensive Hemodialysis and Potential Risks With Increasing Treatment.language
dc.typeArticlelanguage
refterms.dateFOA2021-06-03T10:09:38Z


Files in this item

Thumbnail
Name:
(336) Amer Jrnl Kidn Diseases.pdf
Size:
320.8Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record